Use of ultrasound-guided axillary node core biopsy in staging of early breast cancer.
The aim of this study was to see how effective ultrasound-guided needle biopsy was at detecting lymph node involvement in patients with early breast cancer. Patients with newly diagnosed invasive breast cancer underwent axillary ultrasound (US) where lymph node size and morphology were noted. A core biopsy (CB) was undertaken of any node greater than 5 mm in longitudinal section. Patients with benign CBs proceeded to sentinel lymph node (SLN) biopsy, whereas those with malignancy underwent axillary lymph node dissection (ALND). US and CB findings were correlated with final surgical histology in all cases. One hundred and thirty-nine patients were examined, of whom 52.5% had lymph node metastases on final histology. One hundred and twenty-one patients (87%) underwent axillary node CB. The overall sensitivity of CB for detecting lymph node metastases was 53.4% (60.3% for macrometastases; 26.7% for micrometastases). The US morphological characteristics most strongly associated with malignancy were absence of a hilum and a cortical thickness greater than 4 mm. However, one third of patients with normal lymph node morphology had nodal metastases, and only 12% of these were diagnosed on CB. CB of axillary lymph nodes can diagnose a substantial number of patients with lymph node metastases, allowing these patients to proceed directly to ALND, avoiding unnecessary SLN biopsy.
Britton
P D
PD
Department of Radiology Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge, UK. peter.britton@addenbrookes.nhs.uk
Goud
A
A
Godward
S
S
Barter
S
S
Freeman
A
A
Gaskarth
M
M
Rajan
P
P
Sinnatamby
R
R
Slattery
J
J
Provenzano
E
E
O'Donovan
M
M
Pinder
S
S
Benson
J R
JR
Forouhi
P
P
Wishart
G C
GC
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001365:Axilla / Q000473:pathology; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging*; D055088:Early Detection of Cancer; D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000000981:diagnostic imaging* / Q000473:pathology*; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging / Q000379:methods*; D012680:Sensitivity and Specificity; D021701:Sentinel Lymph Node Biopsy / Q000379:methods*; D014463:Ultrasonography
Radiology. 2004 Feb;230(2):543-52
14699178
Radiology. 2004 Mar;230(3):727-34
14990839
Eur J Cancer. 2003 May;39(8):1068-73
12736105
Radiology. 2002 Nov;225(2):527-36
12409591
Ann Surg Oncol. 2006 Jan;13(1):31-5
16372147
World J Surg. 1997 Mar-Apr;21(3):270-4
9015169
Br J Cancer. 2003 Oct 6;89(7):1310-3
14520465
AJR Am J Roentgenol. 2001 Apr;176(4):1069-74
11264113
J Clin Oncol. 2005 Oct 20;23(30):7703-20
16157938
Cancer. 1983 Nov 1;52(9):1551-7
6352003
Breast Cancer Res Treat. 2006 Sep;99(2):203-8
16541308
Eur J Radiol. 2005 Dec;56(3):382-5
16024205
Radiology. 1997 Dec;205(3):831-5
9393544
Br J Surg. 1999 Nov;86(11):1459-62
10583296
Cancer. 2005 Jan 15;103(2):358-67
15593354
Eur J Cancer. 2003 Jan;39(2):170-4
12509948
Radiology. 1992 Apr;183(1):215-20
1549675
Lancet Oncol. 2007 Oct;8(10):881-8
17851130
Eur J Surg Oncol. 2001 Mar;27(2):141-5
11289748
Cancer. 2002 Sep 1;95(5):982-8
12209680
Br J Cancer. 2003 Mar 10;88(5):702-6
12618878
Eur J Cancer. 2003 May;39(8):1037-8
12736100
Lancet Oncol. 2006 Dec;7(12):983-90
17138219
Can Assoc Radiol J. 2005 Dec;56(5):289-96
16579022
Eur Radiol. 2006 Oct;16(10):2153-60
16670863